Nasus Pharma Announces Data Demonstrating Efficacy of TaffiX® Intranasal Antiviral Protection Against SARS-CoV-2

NEXT STORY
Myriad Announces New Studies Validating the Ability of Myriad’s riskScore® Test to Modify Breast Cancer Risk Prediction
PREV STORY
Reata Announces Promotion and New Hires For Key Leadership Roles
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kantar Health Launches New Oncology Platform, Allowing Healthcare Companies to Better Understand Drug Opportunities

NEW YORK, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Kantar Health, a leading global healthcare ...

author_avatar
NASDAQ Market News

Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing

author_avatar
NASDAQ Market News

1st Choice Health & Wellness Now Offering Boston Heart Diagnostics

NEW ALBANY, Ind., Aug. 21, 2017 (GLOBE NEWSWIRE) -- 1st Choice Health & Wellness ...

author_avatar
NASDAQ Market News